Michael H. Davidson to Ligands
This is a "connection" page, showing publications Michael H. Davidson has written about Ligands.
Connection Strength
0.203
-
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. J Am Soc Nephrol. 2021 01; 32(1):211-222.
Score: 0.175
-
Selective regulation of cytoskeletal tension and cell-matrix adhesion by RhoA and Src. Integr Biol (Camb). 2014 Aug; 6(8):743-54.
Score: 0.028